A strategic partnership between Xifin Inc, San Diego, and PriorAuthNow, Columbus, Ohio, aims to bring an integrated, automated, and simplified prior authorization process to diagnostic laboratories.
The integration of PriorAuthNow’s platform with the intelligent automation of Xifin’s Revenue Performance Management (RPM) 9 solution will optimize the process for both hospital-based and independent labs that handle test orders requiring prior authorization.
PriorAuthNow’s platform securely connects providers’ electronic health record systems with insurance carriers, improving the current process by providing a single location where all prior authorizations can be submitted, monitored, and completed. Xifin RPM 9 then intelligently incorporates the prior authorization information needed for reimbursement at the right time. This unique capability provides numerous benefits for labs, including improved reimbursement, greater accuracy due to intelligent automation, better visibility and transparency to improve performance management, and more clarity regarding policy changes and payor requirements—all while accelerating patient access to care.
Lâle White, Xifin.
According to the companies, the partnership makes Xifin RPM 9 the only diagnostic laboratory revenue cycle management solution with an automated and integrated prior authorization solution to improve workflow, accelerate reimbursement, reduce denials, and make the overall process simple and transparent.
Traditionally, the prior authorization process has been time-consuming and separated from other reimbursement processes, requiring high levels of manual work, such as making phone calls to insurers and sifting through pages of medical records. Meanwhile, the types of tests that require prior authorization—including high-complexity molecular diagnostics and next-generation sequencing—are becoming more common.
“Both hospital-based and independent labs are seeing a steady increase in more complex test orders, such as genetic testing. They need a more efficient way to secure the required prior authorizations on these tests, allowing patients to obtain important diagnostic information in a timely manner while securing the appropriate reimbursement,” says Lâle White, chief executive officer at Xifin. “By partnering with PriorAuthNow, we’re addressing this shift in the healthcare market and giving labs, ordering physicians, patients, and payors significant improvements into the prior authorization process, delivering notable clinical and financial value.”
“We traditionally see a 50% improvement in productivity by leveraging an automated and streamlined solution,” says Ryan Monnin, chief revenue officer at PriorAuthNow. “This ‘found time’ means that healthcare team members can spend time on activities that more directly impact patient care and outcomes. By integrating our platform with Xifin RPM 9, we are marrying two powerful technologies to address a big reimbursement roadblock, and providing prior authorization transparency not available today.”
For more information, visit Xifin and PriorAuthNow.
